Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine vs Olanzapine in Schizophrenia
NCT00182442Phase 4Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of quetiapine in schizophrenia (2 arms), sponsored by Hamilton Health Sciences. Primary endpoints: Changes in neurocognitive test scores at 12 months, Changes in measures of community functioning at 12 months and 1 more. Started Oct 2003; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00182442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182442.